Cargando…
First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone
Synthetic cannabinoids- (SCs-) induced psychosis is a growing public health concern. It leads to significant impairment, including emotional distress, difficulty communicating, and other debilitating symptoms. In this case report, we discuss a patient with no previous history of psychotic symptoms,...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939204/ https://www.ncbi.nlm.nih.gov/pubmed/27429822 http://dx.doi.org/10.1155/2016/7257489 |
_version_ | 1782441972468809728 |
---|---|
author | Roberto, Aaron J. Lorenzo, Aileen Li, Kevin J. Young, Jonathan Mohan, Abhishek Pinnaka, Subhash Lapidus, Kyle A. B. |
author_facet | Roberto, Aaron J. Lorenzo, Aileen Li, Kevin J. Young, Jonathan Mohan, Abhishek Pinnaka, Subhash Lapidus, Kyle A. B. |
author_sort | Roberto, Aaron J. |
collection | PubMed |
description | Synthetic cannabinoids- (SCs-) induced psychosis is a growing public health concern. It leads to significant impairment, including emotional distress, difficulty communicating, and other debilitating symptoms. In this case report, we discuss a patient with no previous history of psychotic symptoms, presenting with first-episode psychosis in the context of progressive, acutely worsening, disorganized, psychotic thoughts and behaviors following prolonged use of SCs. We also discuss relevant literature on SCs-induced psychosis, highlighting its prevalence, presentation, diagnosis, and recommended management. It is important to diagnose and treat SCs-induced psychosis as early and efficiently as possible, in order to alleviate symptoms while limiting functional impairment and emotional distress to the patient. |
format | Online Article Text |
id | pubmed-4939204 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-49392042016-07-17 First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone Roberto, Aaron J. Lorenzo, Aileen Li, Kevin J. Young, Jonathan Mohan, Abhishek Pinnaka, Subhash Lapidus, Kyle A. B. Case Rep Psychiatry Case Report Synthetic cannabinoids- (SCs-) induced psychosis is a growing public health concern. It leads to significant impairment, including emotional distress, difficulty communicating, and other debilitating symptoms. In this case report, we discuss a patient with no previous history of psychotic symptoms, presenting with first-episode psychosis in the context of progressive, acutely worsening, disorganized, psychotic thoughts and behaviors following prolonged use of SCs. We also discuss relevant literature on SCs-induced psychosis, highlighting its prevalence, presentation, diagnosis, and recommended management. It is important to diagnose and treat SCs-induced psychosis as early and efficiently as possible, in order to alleviate symptoms while limiting functional impairment and emotional distress to the patient. Hindawi Publishing Corporation 2016 2016-06-26 /pmc/articles/PMC4939204/ /pubmed/27429822 http://dx.doi.org/10.1155/2016/7257489 Text en Copyright © 2016 Aaron J. Roberto et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Roberto, Aaron J. Lorenzo, Aileen Li, Kevin J. Young, Jonathan Mohan, Abhishek Pinnaka, Subhash Lapidus, Kyle A. B. First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone |
title | First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone |
title_full | First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone |
title_fullStr | First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone |
title_full_unstemmed | First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone |
title_short | First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone |
title_sort | first-episode of synthetic cannabinoid-induced psychosis in a young adult, successfully managed with hospitalization and risperidone |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939204/ https://www.ncbi.nlm.nih.gov/pubmed/27429822 http://dx.doi.org/10.1155/2016/7257489 |
work_keys_str_mv | AT robertoaaronj firstepisodeofsyntheticcannabinoidinducedpsychosisinayoungadultsuccessfullymanagedwithhospitalizationandrisperidone AT lorenzoaileen firstepisodeofsyntheticcannabinoidinducedpsychosisinayoungadultsuccessfullymanagedwithhospitalizationandrisperidone AT likevinj firstepisodeofsyntheticcannabinoidinducedpsychosisinayoungadultsuccessfullymanagedwithhospitalizationandrisperidone AT youngjonathan firstepisodeofsyntheticcannabinoidinducedpsychosisinayoungadultsuccessfullymanagedwithhospitalizationandrisperidone AT mohanabhishek firstepisodeofsyntheticcannabinoidinducedpsychosisinayoungadultsuccessfullymanagedwithhospitalizationandrisperidone AT pinnakasubhash firstepisodeofsyntheticcannabinoidinducedpsychosisinayoungadultsuccessfullymanagedwithhospitalizationandrisperidone AT lapiduskyleab firstepisodeofsyntheticcannabinoidinducedpsychosisinayoungadultsuccessfullymanagedwithhospitalizationandrisperidone |